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Abstract
The mitochondrial b-oxidation system is one of the central metabolic pathways of energy metabolism in mammals. Enzyme
defects in this pathway cause fatty acid oxidation disorders. To elucidate the role of 2,4-dienoyl-CoA reductase (DECR) as an
auxiliary enzyme in the mitochondrial b-oxidation of unsaturated fatty acids, we created a DECR–deficient mouse line. In
Decr
2/2 mice, the mitochondrial b-oxidation of unsaturated fatty acids with double bonds is expected to halt at the level of
trans-2, cis/trans-4-dienoyl-CoA intermediates. In line with this expectation, fasted Decr
2/2 mice displayed increased serum
acylcarnitines, especially decadienoylcarnitine, a product of the incomplete oxidation of linoleic acid (C18:2), urinary
excretion of unsaturated dicarboxylic acids, and hepatic steatosis, wherein unsaturated fatty acids accumulate in liver
triacylglycerols. Metabolically challenged Decr
2/2 mice turned on ketogenesis, but unexpectedly developed hypoglycemia.
Induced expression of peroxisomal b-oxidation and microsomal v-oxidation enzymes reflect the increased lipid load,
whereas reduced mRNA levels of PGC-1a and CREB, as well as enzymes in the gluconeogenetic pathway, can contribute to
stress-induced hypoglycemia. Furthermore, the thermogenic response was perturbed, as demonstrated by intolerance to
acute cold exposure. This study highlights the necessity of DECR and the breakdown of unsaturated fatty acids in the
transition of intermediary metabolism from the fed to the fasted state.
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Introduction
Fatty acids are amphipathic molecules that have indispensable
roles in many cellular functions. In addition to energy storage in
the form of triacylglycerols, fatty acids are involved in the synthesis
of membrane lipids and in signal transduction and endocrine
processes. When carbohydrates are depleted as an energy source
during fasting and starvation, triacylglycerol stores are mobilized
and acetyl-CoAs produced by hepatic b-oxidation of fatty acids
are condensed to ketone bodies to ensure an alternative fuel source
for extrahepatic tissues, such as brain, skeletal muscle, and cardiac
muscle.
Inherited disorders of mitochondrial b-oxidation are among
the most common inborn errors of metabolism affecting infants
and children. Although clinical phenotypes vary, the inability to
completely utilize fatty acids during periods of increased energy
requirement is common to all ß-oxidation disorders. Under
normal conditions, patients are usually asymptomatic, but when
challenged with short-term fasting during infectious illness,
severe and even fatal phenotypes arise. Disease states can
manifest as one or more of the following characteristics: liver
dysfunction, hypoketotic hypoglycemia, organic aciduria, skeletal
myopathy, and elevated fatty acid concentrations in the serum
and tissues [1].
The presence of cis double bonds in naturally occurring (poly2)
unsaturated fatty acids poses problems for ß-oxidation, that
require a few auxiliary enzymes (for review, see [2]). During
degradation, double bonds in odd-numbered positions (e.g., oleic
acid) lead to D
3-enoyl-CoAs, which must be isomerized by an
enoyl-CoA isomerase (ECI) (Figure 1, center pathway). Double
bonds in even-numbered positions give rise to conjugated D
2,D
4-
dienoyl-CoAs, which cannot be hydrated by the enoyl-CoA
hydratases for thermodynamic reasons [3]. In eukaryotes, they are
reduced by an NADPH-dependent 2,4-dienoyl-CoA reductase
(DECR) to 3-enoyl-CoA, which is then isomerized by ECI to trans-
2-enoyl-CoA, suitable for further oxidation (Figure 1, left
pathway). DECR may also play a role in the degradation of fatty
acids containing odd-numbered double bonds because the
PLoS Genetics | www.plosgenetics.org 1 July 2009 | Volume 5 | Issue 7 | e1000543intermediate 2,5-dienoyl-CoA may be isomerized by ECI to 3,5-
dienoyl-CoA and then converted to 2,4-dienoyl-CoA by a specific
D
3,5,D
2,4-dienoyl-CoA isomerase (Figure 1, right pathway) [4,5].
In mammals, both mitochondria and peroxisomes contain the full
set of these auxiliary enzymes for the breakdown of unsaturated
fatty acids [2].
Mammalian mitochondrial isoforms of DECR have been
characterized at the nucleotide [6–8] and protein level [9–13],
and the structure of the human 120 kD isoform has been recently
solved [14]. Another mitochondrial isoform with a molecular mass
of 60 kD has been partially purified, but it has not been
characterized at the molecular level.
Although the impact of (poly)unsaturated fatty acids on human
well-being has been broadly discussed in both the media and the
scientific literature, our understanding regarding the b-oxidation
of unsaturated fatty enoyl-CoA esters in a physiological context is
limited. Most reported cases of mitochondrial b-oxidation
disorders have been related to failures in the oxidation of saturated
fatty acids. However, the importance of the complete oxidation of
(poly)unsaturated fatty acids for human health has been shown by
the case of a patient with a deficiency in mitochondrial DECR
activity who died at the age of four months [15].
Excluding Eci null mutant mice [16], the available mouse
models address only the breakdown of saturated fatty acids. To
study the role of mitochondrial DECR in mammalian metabolism,
we generated a mouse model in which Decr was disrupted by
homologous recombination. Disruption of Decr leads to intolerance
to fasting, as indicated by hypoglycemia, hepatic microvesicular
steatosis, and an altered fatty acid pattern in the liver and serum.
Contrary to many other animal models of fatty acid oxidation
disorders in which hypoglycemia is associated with hypoketone-
mia, the absence of DECR activity did not alter the ketogenic
response to fasting. A compromised response to stress was also
manifested by the inability to maintain a normal body temperature
during cold exposure.
Results
Generation of Decr
2/2 Mice
A replacement vector was designed as described under
Materials and Methods to replace a 0.5-kb region in the Decr
locus by homologous recombination. This region containing the
first exon of Decr was replaced with a neo selection cassette in
targeted RW4 cells (Figure 2A). Correct targeting was verified by
Southern blotting. A 1-kb probe hybridizing to the promoter
region of the Decr gene, which is not present in the replacement
vector, labeled a 5.8-kb fragment in the wild type allele formed
after BamHI digestion. Hybridization of the probe to a 4.7-kb
fragment of the digested allele from Decr
2/2 mice confirmed the
correct insertion of the neo cassette (Figure 2B). Chimeric mice
were produced by microinjecting correctly targeted RW4 cells into
C57BL/6 blastocysts. Chimeric mice were backcrossed onto
C57BL/6 mice to produce Decr
+/2 and finally Decr
2/2 mice.
The different mouse genotypes were distinguished by PCR using
genomic DNA (Figure 2C).
Immunoblotting of mitochondrial extracts from liver, muscle
and heart with an antibody against human DECR revealed a
detectable signal from wild type mice, whereas no signal could be
detected for homozygous null mutant mice (Figure 2D). The
reductase activity (n=3) measured in liver (muscle) mitochondrial
extract was 2.260.6 mmol/min per mg of protein (2.660.3 mmol/
min per mg protein) and 0.560.1 mmol/min per mg of protein
(trace) for wild-type and Decr
2/2 mice, respectively. It is likely
that the observed ‘‘residual activity’’ represents the activity of
recently characterized mitochondrial 2-enoyl thioester reductase
(EC 1.3.1.38) [17], which functions in mitochondrial fatty acid
synthesis and can also reduce 2,4-hexadienoyl-CoA in vitro [18].
Clinical Phenotype
Under standard laboratory conditions, Decr
2/2 mice were
indistinguishable from wild type mice. Crossbreeding of Decr
+/2
mice produced progeny in approximately Mendelian ratios, with
no gender bias (Table 1). Both male and female mutant mice were
viable and fertile. They exhibited weight gain and a life-span
similar to that of wild type mice. Analysis of organ weights and
histological analysis of major organs, including liver, muscle, heart,
kidney, lungs, spleen and intestine, showed no differences between
wild type and mutant mice.
Fasting Intolerance
A common feature of individuals affected with inborn errors of
mitochondrial fatty acid oxidation is that they are asymptomatic
under normal conditions. The same phenomenon is observed in
several animal models of fatty acid oxidation disorders. Clinical
symptoms arise only after metabolic stress, such as prolonged
physical exercise or fasting, which is often associated with
infectious illness. In order to study the effect of metabolic stress
on Decr
2/2 mice, the mice were subjected to fasting for 24 or
48 h.
Altered Lipid Homeostatic Response
During and after fasting, the Decr
2/2 mice showed a tendency
to be more passive and unresponsive compared with wild type
mice. Mice were sacrificed and blood and selected organs were
collected for further characterization. No differences were
observed in the levels of serum alanine aminotransferase, alkaline
phosphatase or glutamyl transferase between wild type and Decr
2/2
mice, indicating intact liver cells. Concentrations of different amino
acids in the sera were also comparable (Table S1). The livers of the
Decr
2/2 mice were markedly pale, and liver weights, when
Author Summary
Fatty acids released from triacylglycerols or obtained from
the diet serve as a main energy provider to the heart and
skeletal muscle, and when carbohydrates are scarce, fatty
acids provide energy for the whole organism. Inherited
disorders of mitochondrial b-oxidation are among the
most common inborn errors of metabolism affecting
infants and children. Under normal conditions, patients
are usually asymptomatic; but when challenged with
metabolic stress, severe phenotypes arise. Here we
describe the generation of a mouse model in which the
total degradation of unsaturated fatty acids is prevented
by disruption of an auxiliary enzyme of b-oxidation.
Although degradation of saturated fatty acids proceeds
normally, the phenotype presented here is in many ways
similar to mouse models of the disrupted classical b-
oxidation pathway, but with additional unique features.
The null mutant mice are asymptomatic until exposed to
fasting, during which they switch on ketogenesis, but
simultaneously develop hypoglycemia. A number of
human patients suffer from idiopathic hypoglycemia
(hypoglycemia of unknown cause). Our mouse model links
this disease state to a specific defect in the breakdown of
polyunsaturated fatty acids. Furthermore, it shows that
degradation of unsaturated fatty acids is essential for
balanced fatty acid and energy metabolism, as well as
adaptation to metabolic stress.
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(p,0.01) greater than that of wild type mice (Figure 3). Hematox-
ylin and eosin-stained histological liver sections (Figure 4A and 4B)
obtained during the fed state showed no differences. Fasted Decr
2/2
mice showed normal lobular architecture when compared with wild
type mice, except for the presence of hepatocytes with a foamy
appearance and centralized nuclei, which are characteristics of
microvesicular steatosis (Figure 4C and 4D). Hepatocytes with
extensive microvesicular vacuolation were mainly present in
periportal and midzonal regions, whereas the majority of
hepatocytes in centrilobular regions appeared normal. When Oil
red O staining was performed to stain neutral lipids, the sections
showed massive and homogeneously distributed micro- and
macrovesicular lipid droplet formation, whereas only minor
microvesicular lipid droplet accumulation was present in age-
matched wild type control sections (Figure 4E and 4F). These data
suggested that fasting results in the accumulation of lipids in the
livers of Decr
2/2 mice.
The amounts of circulating non-esterified fatty acids (NEFA) were
analyzed in the sera of Decr
2/2 and wild type mice. Under normal
nutritional conditions, mean serum NEFA levels were comparable
between wild type and Decr
2/2 mice (0.4360.11 mmol/l,
0.5260.03 mmol/l, respectively) but after fasting, the Decr
2/2 mice
demonstrated increased serum NEFA levels, reaching
1.2860.12 mmol/l after 48 h compared with the wild type levels
of 0.6860.16 mmol/l (p,0.001) (Figure 5A).
Altered Glucose Homeostatic Response
A common symptom associated with inherited defects of
mitochondrial fatty acid oxidation is the development of
hypoglycemia in response to fasting, a phenomenon also observed
in several animal models of disrupted mitochondrial fatty acid
oxidation [19–21]. This effect is considered to be caused by
glycogen depletion in combination with an impaired gluconeo-
genic response. In order to analyze whether the defect in
mitochondrial oxidation of (poly)unsaturated fatty acids generates
a similar hypoglycemic condition, serum glucose levels were
determined for wild type and Decr
2/2 mice after 24 h and 48 h of
fasting (Figure 5B). In the fed state, glucose levels were comparable
(11.061.4 mmol/l for wild type and 9.560.6 mmol/l for Decr
2/2
mice). Twenty-four-hour fasting had no effect on the serum
glucose levels of wild type mice (10.960.3 mmol/l), whereas a
significant decrease was observed in the levels in Decr
2/2 mice
(6.660.2 mmol/l, p,0.01). After mice were subjected to pro-
longed fasting (48 h), the glucose levels in Decr
2/2 mice were
further decreased to 2.360.3 mmol/l, whereas the decrease in
wild type mice resulted in a glucose concentration of
5.960.9 mmol/l. These data revealed that Decr
2/2 mice have
an accelerated hypoglycemic response to fasting.
In order to determine whether the hypoglycemic state of the
Decr
2/2 mice after fasting is in part due to more rapid depletion of
glycogen stores, the liver and muscle glycogen concentration was
measured before and after 6 h, 15 h, and 24 h of fasting (Figure 5C
Figure 1. b-oxidation of fatty acids with double bonds at even- or odd-numbered positions in mitochondria. Degradation of fatty acids
with even-numbered double bonds results in 2,4-dienoyl-CoA esters, which are oxidized as shown on the left. 2,5-dienoyl-CoA esters arising from
odd-numbered double bonds can be oxidized either via an isomerase-dependent pathway (middle) or via a reductase-dependent pathway (right).
AD, acyl-CoA dehydrogenase (EC 1.3.3.6, EC 1.3.99.3, EC 1.3.99.13 or EC 1.3.99.-); EH, enoyl-CoA hydratase (EC 4.1.2.17 or EC 4.2.1.74); HD, 3-
hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35 or EC 1.1.1.211); KT, 3-ketoacyl thiolase (EC 2.3.1.16) ; ECI, D
3,D
2-enoyl isomerase (EC 5.3.3.8); DECI,
D
3,5,D
2,4-dienoyl-CoA isomerase (no EC number available); DECR (shown in bold), 2,4-dienoyl-CoA reductase (EC 1.3.1.34).
doi:10.1371/journal.pgen.1000543.g001
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similar between wild type and Decr
2/2 mice. As expected, fasting
resulted in a gradual depletion of glycogen stores, and no
significant differences in glycogen content between wild type and
Decr
2/2 mice were found at any observation time points.
Figure 2. Targeting of the Decr locus and verification of gene inactivation. (A) Schematic drawing of the targeting strategy showing the
wild type allele, targeting vector and targeted allele after homologous recombination. The targeted allele depicts the strategy used to delete exon 1,
in which the endogenous sequence is replaced by a neomycin-positive selection cassette (neo). A thymidine kinase cassette (tk) was used for
negative selection. Exons are denoted as numbered solid bars (1–9). Recognition sites for restriction endonucleases are marked as B=BamHI,
H=HindIII, E=EcoRI, S=SmalI, EV=EcoRV. The genomic fragment used as an external probe for Southern analysis is marked with an ‘‘X’’, and the
expected fragments for the wild type and targeted allele after BamHI digestion are indicated with arrows. (B) Southern blot analysis of mouse liver
DNA. Genomic DNA was digested with BamHI and detected using probe X to yield the expected fragments of 5.8 kb for the wild type allele in Decr
+/+
mice (+/+), 4.7 kb for the targeted allele in Decr
2/2 mice (2/2), and both fragments in heterozygous Decr
+/2 mice (+/2). (C) Mouse genotypes were
determined from tail samples using PCR with primers denoted with arrows a, b, and c in the schematic drawing. The amplified fragment for wild type
Decr
+/+ mice was 382 bp, 280 bp for homozygous Decr
2/2 mice, and both fragments were amplified from heterozygous Decr
+/2 mice. (D) Western
blot analysis of mitochondrial homogenates from liver, muscle and heart using an antibody against rat DECR showing the presence or absence of the
33-kDa band corresponding to DECR in Decr
+/+ and Decr
2/2 mice, respectively. Twenty micrograms of protein was loaded in each lane.
doi:10.1371/journal.pgen.1000543.g002
Table 1. Genotype analysis of progeny resulting from
crossbreeding Decr
+/2 mice.
Mouse
group
Mice with indicated genotype
(% of total)
Mice with
indicated gender
(% of total)
+/++ /22 /2
Female 15 32 19 66 (52.0)
Male 14 31 16 61(48.0)
Total 29 (23) 63 (49) 35 (28) 127
doi:10.1371/journal.pgen.1000543.t001
Figure 3. Effects of fasting on organ weights in wild-type and
Decr
2/2 mice. Age-matched male mice were fasted for 24 h, after
which they were sacrificed. The wet weight of selected organs (heart,
liver, kidney and fat) was determined and compared between wild type
and Decr
2/2 mice. Weights were calculated as a percentage of body
weight and are expressed as means6SE of 4–6 mice of each genotype
per group. Asterisks (*) denote significant differences (p,0.01) between
wild type and Decr
2/2 mice.
doi:10.1371/journal.pgen.1000543.g003
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glycemia and defective mitochondrial fatty acid oxidation. The
hypoketotic state is caused by an inability of mitochondria to offer
enough acetyl-CoA moieties (products of b-oxidation) for ketone
body production during fasting. Hypoketotic hypoglycemia is a
condition that is used in the diagnosis of human genetic defects to
establish a link between symptoms and a fatty acid oxidation defect.
To study the ketogenic response to fasting, serum b-hydroxybuty-
rate levels were measured in Decr
2/2 and wild type mice under the
fed state and after 24 h of fasting (Figure 5E). In the fed state, the
formation of ketone bodies was very low, as indicated by values of
0.1360.01 mmol/l and 0.1660.06 mmol/l for wild type and
Decr
2/2 mice, respectively. Fasting greatly increased serum b-
hydroxybutyrate values in the wild type and Decr
2/2 mice and
comparable values of 1.0460.14 mmol/l for wild type and
1.1160.10 for Decr
2/2 mice indicated that the reduced capacity
Figure 4. Histological assessment of liver morphology in fasted and non-fasted wild-type and Decr
2/2 mice. Light microscopic images
of representative paraffin-embedded liver sections from wild type (+/+) and Decr
2/2 mice (2/2) stained with hematoxylin and eosin (A–D) and
cryosections stained with Oil red O (E,F). Liver morphology of non-fasted animals showed no differences between wild type and Decr
2/2 mice (A,B).
Fasting for 24 h revealed no apparent changes in the liver morphology of wild type mice, but induced microvesicular steatosis in Decr
2/2 mice, as
observed by the appearance of foamy hepatocytes with centralized nuclei (C,D). Oil red O staining of neutral fat in representative liver cryosections
revealed small, lightly stained vacuoles in the wild type sample (E), whereas a large number of intensively stained vacuoles of varying size can be seen
in Decr
2/2 mice (F), indicating the accumulation of fat. Magnification620.
doi:10.1371/journal.pgen.1000543.g004
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Decr
2/2 mice did not prevent a normal ketogenic response.
Altered Fatty Acid Pattern of Total Lipids
To further analyze the role of DECR disruption in hepatic lipid
accumulation, liver lipids were analyzed using positive ion mass
spectrometry, as described under Materials and Methods. Under
fed conditions, there were no significant differences in the amount
or composition of total liver fatty acids between wild type and null
mutant mice, as indicated in Figure 6A. The main fatty acid
species were palmitic acid (C16:0), stearic acid (C18:0), oleic acid
(C18:1), linoleic acid (C18:2), and arachidonic acid (C20:4). Figure 6C
further shows that under fed conditions, the proportion of
saturated fatty acids (SAFA), monounsaturated fatty acids
(MUFA), and polyunsaturated fatty acids (PUFA) in total liver
fatty acids was comparable between wild type and Decr
2/2 mice.
Analysis of liver fatty acids after the mice were fasted for 24 h
(Figure 6B) indicated that fasting had a minor effect on the lipid
content of wild type liver, with an overall increase of 29% in the
concentration of fatty acids. The increase in palmitic (C16:0) and
stearic acid (C18:0) concentrations contributed to the increased
SAFA concentration, whereas the increased linoleic acid (C18:2)
concentration contributed to the increased PUFA concentration.
There were no significant differences in the amount or
composition of total liver fatty acids between wild type and
heterozygous mutant mice.
In Decr
2/2 mice, however, the overall concentration of fatty acids
increased by 108% after fasting. This was in agreement with the
lipid accumulation observed in histological sections by Oil red O
staining. The most profound changes between fasted wild type and
Decr
2/2 mice were observed for the levels of palmitoleic acid (C16:1),
oleic acid, linolenic acid (C18:3) and linoleic acid, which were 2.5- to
3.8-fold higher in Decr
2/2 mice. In comparison to the fed state, the
concentrations of MUFA and PUFA increased by 288% and 254%,
respectively, in Decr
2/2 mice (Figure 6B). The increased concen-
trations of MUFA were due to the increase in oleic acid and
palmitoleic acid concentrations, whereas the increased PUFA
concentrations were due to the increased linoleic acid and linolenic
acid concentrations. The effect of fasting was most pronounced for
the concentrations of linoleic and linolenic acids, which were
increased 5.5-fold and 6.9-fold when compared with the fed state.
The concentration of SAFA remained relatively unchanged,
although an increase in the concentration of palmitic acid and a
decrease in the concentration of stearic acid were observed.
Acylcarnitine and Dicarboxylic Acid Analysis
Acylcarnitine profiling is commonly used as a biochemical tool to
diagnose various inherited metabolic disorders. For example, the
Figure 5. Effect of fasting on serum NEFA, glucose, and OH–BUT levels and liver and muscle glycogen content in wild-type and
Decr
2/2 mice. Age-matched male wild type (open boxes/bars) and Decr
2/2 mice (solid boxes/bars) were fasted for 0, 24, and 48 h, after which the
serum levels of non-esterified fatty acids (A) and glucose (B) were determined. Glycogen content of liver (C) and muscle (D) tissue from wild type
(open bars) and Decr
2/2 mice (solid bars) in the fed state and after mice were fasted for 6 h and/or 15 h was analyzed using the phenol-sulfuric acid
method. Serum b-hydroxybutyric acid levels were measured in the fed state and after 24 h of fasting (E). At each time point, the results are expressed
as means6SE of 5–6 mice of each genotype per group. Significant differences in glucose and NEFA concentrations between wild type and Decr
2/2
mice are indicated by asterisks (* p,0.05, ** p,0.01).
doi:10.1371/journal.pgen.1000543.g005
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often performed by analyzing serum or plasma acylcarnitines.
Disruption of mitochondrial b-oxidation of long-chain fatty acids
leads to intramitochondrial accumulation of acyl-CoA esters, which
leak into the blood stream as acylcarnitines after transesterification
with carnitine. This means that the serum acylcarnitine profile
reflects acyl-CoA esters that accumulate intramitochondrially and
pinpoints the site of metabolic block in the oxidation pathway.
To study the effect of Decr gene disruption on the acylcarnitine
profile and whether disruption leads to the secretion of specific
acylcarnitine species, serum acylcarnitine profiles were determined
for non-fasted and fasted wild type and Decr
2/2 mice by mass
spectrometry. Undernon-fasted conditions, therewere no significant
differences in the levels of total serum acylcarnitines between wild
typeandDecr
2/2mice(263629 nM and240616 nM,respectively).
In addition, no significant differences were detected in the levels of
individual acylcarnitines from C8 to C20 (Figure 7A). Predominant
acylcarnitines in the sera were C16 and C18:1 acylcarnitines. Fasting
increased the total concentration of acylcarnitines by 2-fold in wild
type mice (567632 nM); however, in Decr
2/2 mice, a markedly
higher 9-fold increase was observed (21506230 nM). Compared
with wild type mice, the levels of all analyzed acylcarnitine species
werehighlyelevated inDecr
2/2 mice. The increasewas mostdistinct
for the level of decadienoylcarnitine (C10:2), the concentration of
Figure 6. Fatty acid pattern of total liver lipids in fasted and non-fasted wild-type and Decr
2/2 mice. Total fatty acids were isolated from
pooled liver homogenate samples of 5–6 mice per genotype and analyzed using positive ion mass spectrometry. (A) Fatty acid profile of total liver
fatty acids under normal fed state conditions showing the concentrations of different fatty acids for wild type (open bars) and Decr
2/2 (solid bars)
mice. (B) Fatty acid profile of liver total fatty acids after fasting for 24 h showing increased concentrations of unsaturated fatty acids in Decr
2/2 mice
when compared with wild type mice. (C) Proportions of saturated fatty acids (SAFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty
acids (PUFA) among the total liver fatty acids in wild type (WT) and Decr
2/2 (KO) mice in the fed state and after 24 h of fasting (fasted).
doi:10.1371/journal.pgen.1000543.g006
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2/2 mice compared with
wild type controls (Figure 7B).
To analyze the excretion of dicarboxylic acids, another marker
for mitochondrial b-oxidation dysfunction, mice were housed in
metabolic cages and urine was collected for 24 h (fed state sample).
Subsequently, food was removed and collection was continued for
another 24 h (fasted sample). Dicarboxylic acid contents were
monitored by means of mass spectrometry. A significant excretion
of molecules with masses corresponding C7:2,C 8:2,C 10:2,C 10:3,
and C14:3 dicarboxylic acids was observed in Decr
2/2 mice after
fasting. The excretion of these dicarboxylic acids, especially C10:2
and C14:3, which were not detected in the urine of wild type mice,
was also observed in the fed state for Decr
2/2 mice (Table S2 and
Figure S1). C8:2 and C10:2, the expected products of linoleic acid
degradation, reached concentrations of 154 mM and 72 mM,
respectively, while C14:3, which is expected product of a linolenic
acid, was found up to 16 mM. In the urine of wild type mice, their
concentrations, with the exception of C8:2, were close to or below
detection limit (approx. 5 mM).
Quantitative Real-Time PCR Analysis of Gene Expression
Adaptation to fasting is partially transmitted via altered
transcription of genes encoding enzymes that function in multiple
pathways. These alterations are directed by transcription factors,
coactivators and corepressors that act as sensors of the nutritional
status of an organism. To analyze whether disturbances observed
in Decr
2/2 mice were accompanied by altered expression of genes
encoding proteins involved in mitochondrial and extramitochon-
drial (peroxisomal and microsomal) fatty acids and carbohydrate
metabolism, quantitative real-time PCR method was conducted.
When the expression levels of several mitochondrial b-oxidation
enzymesinthe liver were compared between wild typeandDecr
2/2
mice (Figure 8), a 2-fold increase was observed in the expression
level of the rate-limiting enzyme carnitine palmitoyltransferase
(CPT-1) in Decr
2/2 mice. Expression levels of other studied
mitochondrial b-oxidation enzymes, long chain acyl-CoA dehydro-
genase (LCAD) and very long chain acyl-CoA dehydrogenase
(VLCAD) were comparable, but were slightly increased in Decr
2/2
mice (Figure 8A). A greater change was observed in the expression
levels of genes associated with peroxisomal b-oxidation, because the
expression levels of acyl-CoA oxidase (Acox) and peroxisomal
multifunctional enzyme 1 (MFE1) were 2.3- and 3.4-fold higher in
Decr
2/2 mice, respectively (Figure 8B). In addition, the expression
of ECI, which is one of the auxiliary enzymes that functions in the
oxidation of polyunsaturated fatty acids with double bonds in odd-
numbered positions, was slightly upregulated (1.5-fold). A
Figure 7. Serum acylcarnitine analysis under normal and fasted conditions. Serum acylcarnitines were analyzed for wild type (solid line)
and Decr
2/2 mice (dotted line) by mass spectrometry. (A) Serum acylcarnitine profile under normal conditions, as determined from the mass spectral
data. (B) To determine the serum acylcarnitine profile under fasted conditions mice were subjected to a 24 h fast prior to serum collection. The
concentrations of acylcarnitine are expressed as means6SE of 5–6 mice of each genotype per group.
doi:10.1371/journal.pgen.1000543.g007
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of cytochrome P450 IVA1 (CYP 4A10), which is a key enzyme in
microsomal v-oxidation (Figure 8C). Normally, enzymes involved
in fatty acid synthesis and desaturation are downregulated during
fasting. The expression level of acetyl-CoA carboxylase (Acaca),
which catalyzes the first step in the fatty acid synthesis pathway, was
lower in Decr
2/2 mice, although it was not significant (Figure 8C).
However, the messenger RNA level of the enzyme responsible for
synthesis of monounsaturated fatty acids, stearoyl-CoA desaturase 1
(SCD1), was markedly lower in Decr
2/2 mice (Figure 8C). During
fasting, glucose homeostasis is maintained in part by the production
and utilization of ketone bodies and in part by the production of
glucose via gluconeogenesis. The hypoglycemic response to fasting
prompted us to study the expression of phosphoenoylpyruvate
carboxykinase (PEPCK-C) and glucose-6-phosphatase (G6Pase),
key enzymes in the gluconeogenesis and glyceroneogenesis
pathway, as well as mitochondrial 3-hydroxy-3-methylglutaryl-
CoA synthase (HMGCS), an enzyme required for ketone body
synthesis (Figure 8D). We found that the levels of PEPCK and
G6Pase were decreased (2- and 2.2-times, respectively) in Decr
2/2
mice, whereas no differences were detected in the levels of
HMGCS. Glucose homeostasis is regulated systemically by
hormones such as insulin and glucagon and at the cellular level
by energy status. During fasting, glucagon enhances glucose output
from the liver via a PKA signal transduction pathway by activating
cyclic AMP-responsive element binding protein (CREB), which in
turn activates the expression of PPARc coactivator-1a (PGC-1a)
[22]. PGC-1a has been ascribed a central role in controlling the
transcription of genes involved in major metabolic pathways in the
liver (mitochondrial biogenesis, fatty acid catabolism, oxidative
phosphorylation, and mitochondrial biogenesis) through the
coactivation of several nuclear receptors and other transcription
factors [23]. During fasting, increased PGC-1a levels in the liver
induce gluconeogenesis by activating PEPCK and G6Pase
promoters through direct interaction with hepatic nuclear factor
4a (HNF4a) and forkhead box transcription factor, FOXO1.
Interestingly, we observed significantly decreased expression levels
of CREB and PGC-1a (2.1 and 2.8-times, respectively) in Decr
2/2
mice compared with wild type mice after fasting (Figure 8E).
Although peroxisome proliferator activated receptor a (PPARa) has
a central role in the transcriptional control of genes encoding fatty
acid oxidation enzymes, further transcription factors are responsible
for the regulation of other metabolic pathways (e.g., sterol
regulatory element-binding protein (SREBP), which regulates genes
involved in lipogenesis, cholesterogenesis, and glucose metabolism
and carbohydrate responsive element binding protein (chREBP),
which mediates the transcriptional effects of glucose on glycolytic
and lipogenic genes). Fasting produced no differences in the
expression level of PPARa between wild type and Decr
2/2 mice;
however, the expression levels of SREBP1 and chREBP in Decr
2/2
mice were significantly repressed (0.3 and 0.25 times the level
observed in wild type mice after fasting) (Figure 8E).
Cold Intolerance and Physical Activity
In order to determine the effects of cold stress, mice were fasted
for 20 h and exposed to a cold environment (+4uC) for 4 h. Decr
2/2
mice exhibited severe cold intolerance during acute cold exposure
and the experiment was terminated when body temperature
decreased below 25uC. It has been shown that mice with
temperatures below 25uC do not recover, and thus this body
temperature can be considered terminal without using death as an
end-point [24]. After exposure for 2 h, the average body
Figure 8. Effect of fasting on hepatic expression levels of genes for mitochondrial and extramitochondrial fatty acid metabolism.
Quantitative real-time PCR analysis was used to determine changes in hepatic gene expression in Decr
2/2 mice (solid bars) after 24 h of dietary stress
compared with wild type mice (open bars). (A) Relative expression levels of genes involved in mitochondrial b-oxidation; CPT-1, LCAD, and VLCAD. (B)
Relative expression levels of genes involved in the peroxisomal b-oxidation pathway; Acox, MFE1 and ECI. (C) Relative expression levels of genes
involved in fatty acid synthesis, desaturation and microsomal v-oxidation; Acaca, SCD1 and Cyp4A10, respectively. (D) Relative expression levels of
genes involved in the gluconeogenetic pathway and ketone body synthesis; PEPCK, G-6Pase and HMGCS, respectively. (E) Relative expression levels
of genes encoding transcriptional factors; PPARa, Srebp1, chREBP, CREB, and the co-activator PGC-1a. For relative quantification of gene expression,
the results were normalized using GAPDH as an endogenous control for each sample, and the data obtained for wild type samples were set to 1.
Results represent means6SE of 5 mice of each genotype per group. Statistically significant differences in expression levels between wild type and
Decr
2/2 mice are indicated by asterisks (* p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.pgen.1000543.g008
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2/2 mice (n=5) was 23.4uC compared with
33.0uC for wild type mice, and three of the five Decr
2/2 mice
demonstrated temperatures that had declined below 25uC (average
21.3uC). The temperatures of the two remaining Decr
2/2 mice
continued to decline linearly and averaged 21.6uC after 3 h, at
which timethe experiment was terminated(Figure 9).Shivering was
also initially present in Decr
2/2 mice but decreased during the
experiment and was absent after 2 h, at which time mice became
lethargic. In contrast, none of the 5 wild type mice succumbed to
cold and, at the end of the 4 h exposure, shivering was clearly
present and the average body temperature was 34.5uC. The
severely cold intolerant phenotype of Decr
2/2 mice was observed
only if cold exposure was preceded by fasting (data not shown).
As previously mentioned, Decr
2/2 mice showed decreased blood
glucose and elevated NEFA concentrations after fasting in
comparison to wild type mice. This response was more
pronounced in both mouse genotypes when the fasting period
was followed by acute cold exposure. When cold exposure was
terminated, Decr
2/2 mice demonstrated glucose and NEFA
concentrations of 3.060.2 mmol/l and 1.660.02 mmol/l, respec-
tively, whereas the values obtained for wild type mice were
6.360.5 mmol/l and 0.7760.08 mmol/l.
To analyze the physical activity of mice during fasting and cold
exposure, a LabMaster study was conducted. This study showed
that during fasting wild type mice maintained a normal activity
pattern, in which activity was highly enhanced during the dark
period. When total activity during the 48 h fast was determined,
Decr
2/2 mice showed significantly lower average activity counts
than wild type mice; in particular, their activity was greatly
reduced during the dark period (Figure 10A). Average total activity
counts were 158630 counts/30 min and 293619 counts/30 min
for Decr
2/2 and wild type mice, respectively (Figure 10B). To
assess activity during cold exposure, mice were fasted for 20 h and
then exposed to the cold for 2 h. At the beginning of the exposure,
Decr
2/2 mice displayed significantly lower activity, reflecting the
effect of fasting, as shown in Figure 10A and 10B. Upon
continuation of cold exposure, the activity of both mouse groups
decreased in a similar manner. However, at the end of the 2 h
exposure period, the activity of Decr
2/2 mice had decreased to
close to zero, whereas wild type mice maintained a reasonable
amount of activity (Figure 10C). Average total activity counts for
wild type and Decr
2/2 mice during cold exposure were 8786183
counts/15 min and 317665 counts/15 min, respectively
(Figure 10D). Average heat production during cold exposure was
also measured, and Decr
2/2 mice showed a slight but significant
decrease in heat production. The average heat production of wild
type and Decr
2/2 mice was 27.161.2 kcal/h/kg and 23.260.8
kcal/h/kg, respectively (Figure 10E).
Discussion
The results presented herein indicate that mitochondrial 2,4-
dienoyl-CoA reductase activity in mice is indispensable for the
complete oxidation of (poly)unsaturated fatty acids and for
adaptation to metabolic stress. Decr
2/2 mice exhibited hypogly-
cemia during fasting, with concomitant accumulation of metab-
olites of unsaturated fatty acids in the liver, sera, and urine.
Furthermore, a predisposition to cold intolerance and a reduction
in diurnal activity during metabolic stress were observed.
Insufficient adaptation to metabolic stress in Decr
2/2 mice is
exemplified by the development of microvesicular hepatic steatosis
after as little as 24 h of fasting. However, levels of serum alanine
aminotransferase, alkaline phosphatase, and glutamyl transferase
were similar in both Decr
2/2 and wild type animals, suggesting
that null mutant mice did not develop liver cell membrane injury
during the observation period.
In the Decr
2/2 mice, analysis of fatty acid composition in total
liver lipids revealed a specific accumulation of mono- and
polyunsaturated fatty acids, with oleic and linoleic acids being
the dominant species. This can be explained in terms of their
impaired b-oxidation, resulting in their channeling toward
esterification and leading ultimately to hepatic steatosis. The fact
that saturated fatty acids, such as palmitic and stearic acids, which,
together with mono- and polyunsaturated fatty acids (especially
oleic and linoleic acid), are the main components of triacylglycer-
ols in adipose tissue [25], did not accumulate suggest that they
were effectively metabolized. The proceeding b-oxidation of
saturated fatty acids explains the carbon source for ketogenesis,
which was found to be similar in wild type and Decr
2/2 mice.
A prominent feature of Decr
2/2 mice is the hypoglycemic
response to fasting, which seems not to be related to differences in
glycogen or amino acid metabolism, but is associated with altered
transcriptional control mechanisms in the gluconeogenesis path-
way. Indeed, there were no significant differences in liver and
muscle glycogen content in wild type and Decr
2/2 mice, either in
the fed or in the fasted state. This finding suggested that the
observed hypoglycemia was not due to a failure in glycogen
metabolism. The amino acid profile and levels in the sera of wild
type and Decr
2/2 mice after fasting were similar (Table S1) giving
no metabolic implications of specific pathological states in Decr
2/2
mice. This indicates that the availability of substrates for
gluconeogenesis, in terms of gluconeogenic amino acids, was not
the limiting factor when hypoglycemia developed in Decr
2/2 mice.
Furthermore, the levels of glucagon and insulin in the fed state and
during fasting showed no marked differences between wild type
and Decr
2/2 mice, indicating that adaptation to fasting was not
affected at the hormonal level.
PEPCK and G6Pase are regarded, under in vivo conditions, as
unidirectional enzymes that, among other factors, control the
gluconeogenetic flux and show increased activity in the fasted
state. The detected low PEPCK and G6Pase mRNA levels can
explain, in part, the hypoglycemia observed in Decr
2/2 mice via
contributing to the decreased flux through the gluconeogenetic
pathway in the liver. Decreased mRNA levels of coactivator PGC-
1a and its inducer CREB, which together drive the expression of
PEPCK and G6Pase via HNF4a and FOXO1, suggest that
Figure 9. Changes in body temperature during cold exposure
with prior fasting. Cold tolerance was tested after 20 h of fasting by
exposing individually housed wild type mice (open boxes) and Decr
2/2
mice (solid boxes) to a +4uC environment for a maximum of 4 hours or
until body temperature dropped below 25uC. Temperature was
measured from the shaved mid-dorsal body surface using an infrared
thermometer. At each time point, body temperatures are presented as
mean values of three measurements from the same individual.
doi:10.1371/journal.pgen.1000543.g009
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fasting are compromised in Decr
2/2 mice. However, which of the
component(s) upstream of PGC-1a or CREB, especially TORC2
(transducer of regulated CREB activity 2), energy sensing kinase
AMPK, and salt-inducible kinase (SIK), are affected and whether
this effect is mediated by certain accumulated PUFA species will
be evaluated in further studies (Figure 11). Analysis of the
expression levels, activity and phosphorylation status of these
factors in Decr
2/2 mice could elucidate the regulatory link
between gluconeogenesis and the disrupted breakdown of
unsaturated fatty acids.
The expression of several genes, including CPT-1, Acox, and
CYP4A1, has been shown to be upregulated by polyunsaturated
fatty acids [26,27]. In addition, unsaturated fatty acids were
previously shown to impact different transcription factors that play
a pivotal role in lipid and carbohydrate metabolism. Thus, the
Figure 10. Effect of fasting and cold exposure on physical activity and heat production. To assess physical activity, Decr
2/2 mice (solid
boxes and bars) and wild type mice (open boxes and bars) were continuously monitored with the LabMaster system. (A) Activity pattern during
48 hours of fasting. Fasting was started at 8 am and continued for 48 hours, with data collected every 30 min. Group means6SEM (n=4) are shown.
(B) Average total activity (counts/30 min) during the 48 h fast. Group means6SEM (n=4) are shown. (C) Total activity during cold exposure. Decr
2/2
and wild type mice were fasted 20 h and then exposed to cold for 2 h (+9.6uC). Total activity was measured continuously and data were collected
every 15 minutes. (D) Average total activity (counts/15 min) during cold exposure. Group means6SEM (n=4) are shown. (E) Average heat production
(kcal/h/kg) during cold exposure. Group means6SEM (n=4) are shown. Student’s t-test was used for statistical analysis, and p-values below 0.05 were
considered statistically significant. Data for total activity during cold exposure were analyzed by two-way ANOVA followed by Bonferroni’s post-test.
doi:10.1371/journal.pgen.1000543.g010
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2/2
mice can act as regulators of gene expression by functioning as
ligands for nuclear receptors, such as PPARa, which is the major
PPAR subtype present in hepatocytes and is involved in regulating
genes involved in lipid and carbohydrate metabolism [28,29]. In
accordance, the expression of the PPARa target genes CPT-1,
Acox, and CYP4A1 was markedly higher after fasting in Decr
2/2
mice compared with wild type mice. Unsaturated fatty acids can
also affect gene expression via SREBP1, a factor considered a key
regulator of triacylglycerol and fatty acid synthesis [30]. Although it
is believed that they function mainly by inhibiting the maturation of
lipogenic SREBP1 [31,32], they have been shown to decrease
hepatic SREBP1 mRNA [33]. In line with these observations, the
mRNA level of SREBP1 was reduced 3-times in Decr
2/2 compared
with wild type mice after fasting, and the levels of SCD1 and Acaca
mRNAs,which aremediated inpartbySREBP1,weredecreasedas
well. PUFA has recently been shown to have a suppressive effect on
lipogenic and glycolytic gene expression through chREBP [34].
Namely, PUFA ablates chREBP translocation from the cytosol to
nucleus and accelerates chREBP mRNA decay [35,36]. Of note,
the Decr
2/2 mice displayed significantly decreased (4-times lower)
levels of chREBP mRNA compared with wild type animals after
fasting, likely reflecting the increased chREBP mRNA decay
mediated by accumulated PUFA.
In our experimental setting of acute cold exposure (4 h) without
prior acclimatization, it is unlikely that nonshivering thermogen-
esis plays any major role in maintaining mouse body temperature.
The decreased heat production observed in Decr
2/2 mice in the
fasted state can be explained by reduced shivering [37]. Reduced
shivering can in turn be explained by the reliance of fast-twitching
muscle fibers on glucose, which is depleted in Decr
2/2 mice under
these conditions. Wild type mice display a diurnal activity pattern
with higher physical activity during the dark phase, and this
pattern is preserved during fasting [38]. This increased dark phase
activity, however, was greatly diminished in fasted Decr
2/2 mice.
Of note, no differences in thermoregulation were observed between
wild type and Decr
2/2 mice in the fed state. Because both animal
groups generated ketone bodies, which can be utilized as fuel in
muscle tissue, the link between simultaneous hypoglycemia and the
incapability to maintain body temperature in Decr
2/2 mice remains
an intriguing open question.
Byinspectingtheacylcarnitine profileofthe sera ofDecr
2/2mice,
one can deduce which paths are used by unsaturated fatty acids
during their degradation. The mitochondrial b-oxidation of
unsaturated fatty acids with preexisting double bonds at even-
numbered positions, such as petroselinic acid (C18:1, D
12), is
predicted to halt in Decr
2/2 mice during the fourth turn of the b-
oxidation cycle after cis-4-decenoyl-CoA is dehydrogenized to trans-
2-cis-4-decadienoyl-CoA (Figure 1, left section). If the double bond
is in an odd-numbered position, such as in oleic acid (C18:1, D
9),
mitochondrial oxidation can proceed to completion via the ECI-
dependent route (Figure 1, middle section) or can be halted during
the third b-oxidation cycle at the level of trans-2-cis-4-tetradecenoyl-
CoA, which can be generated from the 2,5-tetradecenoyl-CoA
intermediate (Figure 1, right section) by the combined activity of
ECI and DECI [39]. For polyunsaturated fatty acids having double
bonds at odd- and even-numbered positions, such as in linoleic acid
(C18:2, D
9,12) , the lack of DECR activity results in blocking of the b-
oxidation of these fatty acids either when intermediates of odd-
numbered bonds are routed to the reductase-dependent pathway or
Figure 11. PUFA and activation of gluconeogenesis. Simplified schematic presentation of the identified kinase cascades regulating
gluconeogenesis. The activation cascade leads to phosphorylation of CREB (cAMP-responsive element binding protein), which, together with TORC2
(transducer of regulated CREB activity 2), drives the expression of coactivator PGC-1a. Transcription of the key gluconeogenic enzymes PEPCK
(phosphoenoylpyruvate carboxykinase) and G6Pase (glucose-6-phosphatase) is induced when PGC-1a associates with HNF4a (hepatic nuclear factor
4a) and FOXO1 (forkhead box transcription factor). Nuclear translocation of TORC2, which is needed for activation of the gluconeogenic program, is
controlled by phosphorylation by activated AMPK (AMP–activated protein kinase) and SIK (salt-inducible kinase). Observed changes in Decr
2/2 mice
are indicated with red arrows. Possible targets of accumulated PUFA or their derivatives are also indicated.
doi:10.1371/journal.pgen.1000543.g011
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4 position
during acyl chain shortening via b-oxidation.
The distinctive accumulation of trans-2,cis-4-decadienoylcarnitine
(C10:2) in the sera of Decr
2/2 mice can be derived from the
incomplete oxidation of unsaturated fatty acids of the v-6 series.
Among them, linoleic acid is the most abundant species in the
animal body, whereas others, such as petroselinic acid, are
substantially less frequent. Because no intermediates of the
reductase-dependent pathway for unsaturated fatty acids with
double bonds at odd-numbered positions were observed, the data
suggest that the major route for b-oxidation of these fatty acids
proceeds via the isomerase-dependent pathway in vivo. If the
reductase-dependent pathway were preferred, it would lead to
accumulation of tetradecatrienoylcarnitine (C14:3, D
2,4,8)a n d
tetradecadienoylcarnitine (C14:2, D
2,4) from the incomplete oxida-
tion of linoleic and oleic acids, respectively. In line with this notion,
the accumulation of C14:2 metabolites (e.g., intermediates of linoleic
acid b-oxidation via the reductase-dependent route) was not
observed. Although total acylcarnitine concentrations in Decr
2/2
mice after fasting were approximately 4-fold higher compared with
those of wild type, the profile of acylcarnitines showed no
distinctively accumulating species other than trans-2,cis-4-decadie-
noylcarnitine. This finding agrees with studies examining the
breakdown of 2,5-octadienoyl-CoA in isolated rat liver mitochon-
dria, namely, most of the test substrate (80%) in this system was
metabolized via the ECI-dependent pathway [40].
The accumulated unsaturated fatty acids observed in Decr
2/2
mice could also act as substrates in alternative oxidation pathways
and processes. The microsomal fatty acid v–hydroxylation can,
together with peroxisomal b-oxidation pathway, provide an
alternative route to prevent the accumulation of fatty acids or
their derivatives in hepatocytes during times of increased lipolysis
[41]. Both v-oxidation and peroxisomal b-oxidation are induced
in Decr
2/2 mice, as indicated by the enhanced expression of
microsomal Cyp4A10 and peroxisomal Acox and MFE1.
Consequently, processing of accumulated unsaturated intermedi-
ates by microsomes and peroxisomes in Decr
2/2 mice can explain
the observed excretion of medium chain unsaturated dicarboxylic
acids into the urine.
Many of the clinical characteristics observed in human patients
suffering from fatty acid oxidation disorders can be reproduced in
mice, as shown for mouse models of SCAD, MCAD, LCAD, and
VLCAD deficiencies [19,20,42,43]. The stress-induced hypogly-
cemia observed in VLCAD-deficient mice was recently shown to
be linked to impaired gluconeogenesis, but whether impairment is
caused by inhibition of certain enzymes in the pathway or due to
alterations at the level of transcription remains unknown [44]. The
mouse model for MCAD does not suffer from hypoglycemia,
although it is cold intolerant and displays lower blood glucose. A
recent study indicated that severe metabolic stress leads to specific
changes in carbohydrate management in MCAD-deficient mice
[45]. Null mutant mouse models for defects in fatty acid
breakdown frequently display more severe phenotypes than the
corresponding deficiencies in humans, although this is not the case
for Decr. To date, only a single clinical case presenting the DECR
deficiency has been published [15]. Metabolic studies revealed
abnormal plasma and urine acylcarnitine profiles, with the
dominant species corresponding to decadienoylcarnitine, hypo-
carnitinemia and hyperlysinemia. Despite carnitine supplementa-
tion and a change in dietary fat to mainly medium-chain
triacylglycerols, the patient died at the age of four months. DECR
activity measured in postmortem liver and muscle samples was
found to be decreased to 40% of the normal activity in liver and
17% of the normal activity found in muscle, as measured using
trans-2-cis-4-decadienoyl-CoA as a substrate [15]. Consistent with
the characteristics of the clinical case, the same dominant carnitine
species was observed in Decr
2/2 mice, although hyperlysinemia
was not observed. An open question, therefore, remains as to
whether the primary cause of patient death was due to DECR
deficiency or whether the patient suffered another disease that
remained undiagnosed.
One mouse model is known in which mitochondrial b-oxidation
of unsaturated fatty acids is halted at the level of their cis-o rtrans-
3-enoyl-CoA intermediates due to disruption of ECI [16]. Similar
to Decr
2/2 mice, Eci
2/2 mice are asymptomatic under fed
conditions but upon fasting, accumulate unsaturated acyl groups
in ester lipids and develop hepatic steatosis. ECI deficiency also led
to dicarboxylic aciduria, with an accumulation of medium chain
unsaturated dicarboxylic acids. However, whether Eci
2/2 mice
have a hypoglycemic response to fasting or show cold intolerance,
as observed for Decr
2/2 mice, was not reported. In addition,
production of ketone bodies was not reported in Eci
2/2 mice.
Thus, a lack of information prevents a thorough comparison of
Eci
2/2 and Decr
2/2 mice.
In the present study, we examined the physiological conse-
quences of disruption of the mitochondrial b-oxidation of
unsaturated fatty acids at the level of 2,4-dienoyl-CoA reductase.
This mouse model provides for the first time a hint that the
breakdown of PUFA is essential for switching on gluconeogenesis
during fasting. Decr
2/2 mice may serve as a model for studying the
mechanism responsible for idiopathic hypoglycemia with unim-
paired ketogenesis in humans. Analysis of the expression profile of
selected transcription factors and cofactors revealed the involve-
ment of CREB and PGC1a upstream of the reduced expression of
PEPCK and G6Pase in Decr
2/2 mice. Among accumulated
acylcarnitines in the sera, trans-2,cis-4-decadienoylcarnitine (C10:2),
which is a potential novel metabolic marker for screening patients
with inborn errors in polyunsaturated fatty acids breakdown, was
found.
Materials and Methods
Generation of Decr Knockout Mice
The genomic clone BACM:109-18E (from 129/SvJ strain)
corresponding to the mouse Decr locus was obtained from Genome
Systems (St Louis, MO, USA). A 3.3 kb EcoRI–HindIII fragment
upstream of the first exon was cloned into a Bluescript vector
modified with SalIa n dClaI sites flanking the polylinker. A 4.4 kb
SmaI–EcoRV fragment from the first intron was cloned into a
Bluescript vector modified with AscIa n dPacI sites flanking the
polylinker. For the replacement vector, SalI–ClaIa n dAscI–PacI
cleaved fragments were ligated to the corresponding sites of the
pPGKneo/TK-2 vector (Figure 2A), where they flanked the
PGKneo cassette. The neomycin resistance (neo) and thymidine
kinase (TK) genes were used for positive and negative selection,
respectively.
Linearized replacement vector was electroporated into RW4
embryonic stem (ES) cells (129/SvJ, Tyr
chp/Tyr
cp) that were
subsequently grown under G418 and ganciclovir selection.
Correctly targeted ES cell clones were identified by Southern
analysis of genomic DNA, for which the BamHI restriction
fragment length polymorphism created by homologous integration
was identified by a 59-probe upstream of the targeted locus
(Figure 2B). Germline chimeric mice were produced by microin-
jecting ES cells from positive clones into C57BL/6 blastocysts at
the Biocenter Oulu Transgenic core facility. Genotyping was
performed by PCR analysis of tail DNA samples using forward
primers for the wild type allele (59- TGC GTT CTT TGC TGG
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CAC TAG TTC TAG CC -39) and a reverse primer for both
alleles (59-CAA ATG AAA GTT CCC TTG TGG AG-39)
(Figure 2C). The size of the amplified products was 382 bp and
280 bp for the wild type and the mutated allele, respectively.
Animal Studies
Four- to seven-months-old mice were used in all experiments.
DECR null mice were backcrossed 9 times onto the C57BL/6
background and C57BL/6 mice were used as wild type controls.
Mice were housed in an animal room with a 12-hour lighting
period (07:00–19:00) and given unrestricted access to water and
standard chow. For fasting experiments, the mice were housed
individually and food was withdrawn for 6 to 48 hours; water was
provided ad libitum. Cold tolerance was tested by exposing
individually housed fasted (20 h) or non-fasted mice to +4uC for
a maximum of 4 hours or until their body temperature dropped
below 25uC. Temperature was measured from the shaved mid-
dorsal body surface using a ThermoScan thermometer (PRO
4000, Braun, Kronberg, Germany), as described earlier [46].
Oxygen consumption, CO2 production, energy expenditure,
determination of food and water intake, and activity (total activity,
ambulatory and fine movement and rearing) were measured
simultaneously and continuously in housing cages utilizing an
indirectopen circuit calorimetrysystemwith adualarrayofinfrared
photo beams (LabMaster, TSE Systems, Bad Homburg, Germany).
Before the experiments were carried out, mice were acclimated to
their new environment in training cages similar to the actual
experimental cages for seven days. During the experiment, mice
were individually housed in Plexiglas home cages, fresh air was
supplied at a constant flow of 0.33 l/min, and O2 consumption and
CO2 production were measured and compared with room air
values. Data were collected every 30 min for 72 h. The respiratory
exchange ratio was calculated by dividing the volume of CO2
production (VCO2) by the volume of oxygen consumption (VO2),
and energy expenditure (heat production) was calculated using the
software provided with the instrument. For fasting studies, mice
were similarly acclimated to the experimental conditions and their
baseline (mice fed ad libitum) was analyzed over 24 hours. Food was
then removed at 8 am and fasting was continued for 48 hours; the
mice were analyzed continuously, as described above. For the cold
exposurestudyintheLabMastersystem,mice werefasted overnight
(20 hours) prior to the experiments. Plexiglas cages were placed in a
refrigerated cold cabinet (Helkama, Finland) with a controlled
temperature (average temperature of 9.6uC) for 2 hours. Data were
collected every 15 minutes and analyzed using Microsoft Excel and
GraphPad Prism version 4.03.
All animals were handled in strict accordance with good animal
practice and their use in the present study was approved by the
University of Oulu committee of animal experimentation. When
provided, the values represent means6S.E.
Immunoblotting and Activity Measurements
To isolate mitochondria from heart and skeletal muscle tissues,
200–500 mg of tissue was cut into small pieces in 10 volumes (w/v)
of isolation buffer (100 mM KCl, 50 mM HEPES, pH 7.4, 5 mM
MgCl2, 1 mM EDTA). The solution was replaced with 10 volumes
of isolation buffer containing 2 mg/ml of the bacterial protease
Nagarse (Sigma, St. Louis, MO, USA) and the tissue samples were
incubated on ice for 5 min. Samples were washed with 10 volumes
of isolation buffer and subsequently homogenized in 10 volumes of
isolation buffer containing 2 mM ATP with a motorized glass-
teflon homogenizer. The suspension was centrifuged at 30006g
for 4 min and the resulting supernatant was further centrifuged at
170006g for 10 min to pellet the mitochondria. The resulting
pellet was suspended in 1.4 volumes of suspension buffer (10 mM
Tris-Cl, pH 7.8, 250 mM sucrose, 0.2 mM EDTA). To produce
the mitochondrial homogenate from liver tissue, 500 mg of tissue
was homogenized in 10 volumes of isolation buffer, followed by
centrifugation as described above and resuspension in suspension
buffer. To minimize peroxisomal contamination, mitochondrial
purification was completed by isopycnic density gradient ultra-
centrifugation on a self-generating Percoll (Sigma) gradient, as
previously described [17]. For immunoblotting, samples contain-
ing 20 mg of protein were transferred to a nitrocellulose membrane
after SDS-PAGE and detected using polyclonal antibody against
rat 2,4-dienoyl-CoA reductase [47] as the primary antibody and
goat anti-rabbit IgG horseradish peroxidase conjugate (Bio-Rad
Laboratories, Hercules, CA, USA) as the secondary antibody,
followed by ECL Western Blotting Detection Reagents (Amer-
sham Biosciences, Piscataway, NJ, USA).
The 2,4-Dienoyl-CoA reductase activity was assayed in
mitochondrial extracts by spectrophotometric measurement of
NADPH consumption at 22uC using 60 mM 2,4-hexadienoyl-CoA
as substrate, as previously described [10].
Blood Chemistry
Blood samples were collected from anesthetized mice by
orbital bleeding in Multivette collection tubes (Sarsted,
Nu ¨mbrecht, Germany) and serum was separated by centrifu-
gation after 15 min. After being bled, mice were sacrificed by
cervical dislocation and tissues were weighed and collected for
further analysis. Serum cholesterol, triacylglycerols, albumin,
alkaline phosphatase, alanine aminotransferase, glutamyl trans-
ferase, b-hydroxybutyrate and amino acids were analyzed by
the clinical laboratory of the University Hospital of Oulu,
Finland. Serum glucose (Glucose, Wako Chemicals, Neuss,
Germany) and free fatty acids (NEFA C, Wako Chemicals) were
determined by enzymatic colorimetric methods. Insulin levels
were measured with the insulin ELISA kit (Chrystal Chem Inc.,
IL, USA) using mouse insulin as a standard. Glucagon was
determined using the glucagon RIA kit (Linco Research Inc,
MO, USA).
Glycogen Analysis
Glycogen content was determined by the phenol–sulfuric acid
method modified from Lo et al. [48]. Portions of frozen liver and
muscle (50–90 mg) were weighed and placed in test tubes
containing 1.0 ml of 5 M KOH solution saturated with sodium
sulfate. The tubes were placed in a boiling water bath for 30 min to
obtain a homogenous solution. Tubes were cooled on ice for 5 min,
and glycogen was precipitated by the addition of 1 ml of 95%
ethanol and incubationon ice for30 min. Samples werecentrifuged
at 8406g for 30 min, after which the supernatants were removed
and the precipitates were dissolved in 3 ml of distilled water.
Aliquots of the glycogen solutions, including standards, were made
up to 1 ml in water. One milliliter of 5% phenol solution and 5 ml
of a concentrated sulfuric acid solution were added in rapid
succession to each tube. The tubes were allowed to stand for 10 min
at room temperature, their contents thoroughly mixed, and the
tubes were further incubated in the water bath (25uC) for 10 min,
followed by measurement of their absorbances at 490 nm.
Mass Spectrometric Analysis of Total Liver Fatty Acids
and Serum Acylcarnitines
Mass spectral analyses were performed using an APEX II
FTICR-MS equipped with an Apollo ESI source (Bruker
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the level of hepatic fatty acids, frozen liver samples were
homogenized in H2O (1:20, w/v) with a Potter homogenizer.
Ten microliters of homogenate was added to Eppendorf tubes in
which 20 ml of 10 mM pentadecanoic acid had been evaporated at
room temperature. Then, 180 mlo fC H 3CN and 20 mlo f5M
HCl was added to the tube and heated for 1 h at 95uC. After being
cooled to room temperature, 190 ml of 1 M KOH was added and
the tubes were again heated for 1 h at 95uC. After being cooled to
room temperature, 100 ml of 5 M HCl was added to the tubes,
and hydrolyzed fatty acids were extracted 2 times with 0.5 ml of
hexane. Combined extracts were evaporated at room temperature
under a stream of nitrogen. The residue was resuspended in 50 ml
of 5% oxalylchloride in CH3CN (v/v) and heated for 5 min at
50uC. The solution was evaporated at room temperature under a
stream of nitrogen. Then, 50 ml of 5% dimethylaminoethanol in
CH3CN (v/v) was added and, after 5 min, the solvent was
evaporated at room temperature under a stream of nitrogen. For
MS measurements, the residue was resuspended in 500 mlo f
MeOH/H2O/Acetic acid [49.5/49.5/1; (v/v/v)] and further
diluted 1:50 in the same solvent.
To determine serum acylcarnitines, 10 mlo f1 0mMd o d e c a -
noyl-carnitine in H2O and 100 ml of serum were added to the
CHromabond C-8 matrix (Macherey-Nagel, Du ¨ren, Germany)
in an Eppendorf tube and mixed. The supernatant was discarded
after centrifugation and the residue was washed twice with
0.5 ml of H2O. Lipids bound to the C-8 material (including the
acyl carnitines) were extracted twice with 0.4 ml of CHCl3/
MeOH (7/2; v/v). Combined extracts were evaporated under a
stream of nitrogen at 65uC. The C-8 material was further
extracted with 0.6 ml of CHCl3/MeOH (7/2; v/v) and the
liquid phase was combined with previously evaporated extracts.
After being mixed, extracts were centrifuged (160006gf o r
1 min) and 550 ml of the liquid phase was carefully transferred to
a new tube. The combined extracts were evaporated under a
stream of nitrogen at 65uC. The dried pellets (containing lipids
including acylcarnitines) were resuspended in 100 mlo fa
solution containing 1 M acetylchloride in MeOH and heated
to 65uC for 15 min. Neutral lipids and acyl-methyl esters were
extracted twice with 0.5 ml of hexane. The upper phase
(containing the methyl esters) was discarded and the lower
phase (containing the acylcarnitines) was evaporated at room
temperature under a stream of nitrogen. Shortly before the MS
measurements, the residues were resuspended in 30 mlo f
MeOH/2%AcOH (50/50; v/v). Mass spectral data were
recorded in positive ion mode by the accumulation of 256 scans
at 256K resolution.
Determination of the Dicarboxylic Acid Content of Urine
Creatinine content was determined in the urine samples using
the method of Popper et al. [49]. The samples were diluted with
phosphate buffered saline to a creatinine concentration of 1 mM.
Methanol solutions (1 mM) of various dicarboxylic acids were used
as standards. Each sample was measured twice: once with
standards containing odd-numbered carbon atoms (C5-, C7-, C9-
, and C11-dicarboxylic acid) and tetradecanedioic (C14) acid as a
reference and once with the standard mixture containing even-
numbered carbon atoms (C4-, C6-, C8-, and C10-dicarboxylic acid)
and tetradecanedioic acid as a reference. When tested separately
the concentration of tetradecanedioic in the urine samples of mice
was below the detection limit of the assay used, allowing the use of
this acid as a reference (see below).
For quantitative determination of the dicarboxylic acids, 10 ml
of standard solution was evaporated under a stream of nitrogen
in eppendorf tubes, followed by the addition of 200 mlo ft h e
normalized urine sample. Non-carboxylic acid lipids were
removed by extraction with three times 0.5 ml diethylether after
increasing the pH with 350 ml 0.3 M NaOH. Carboxylic acids
were extracted three times with 0.5 ml diethylether after the pH
was decreased with 50 ml 6 M HCl. The acid extract was
evaporated in a stream of nitrogen at room temperature. The
residue was dissolved in 100 mlo f2 0m MN , N 9-carbonyldiimi-
dazole in acetonitrile and incubated at room temperature for
1 h. Thirty microliters of a solution containing 21 mlo f
acetonitrile, 3 ml of acetic acid, and 6 ml of phenylethylamine
was added, and the samples were incubated for 1 h at room
temperature. Finally, the entire sample was evaporated under a
stream of nitrogen at 60uC. To desalt the sample, 25 mlo fR P - 1 8
(bed-vol.) (ICN, Eschwege, Germany) was prewashed with
0.5 ml methanol, resuspended in 0.5 ml of 0.1% TFA in
acetonitrile (9/1, v/v), and added to the evaporated assay-
mixture, followed by mixing and centrifugation. The supernatant
was then discarded and the residue was again washed with
0.5 ml of 0.1% TFA in acetonitrile (9/1, v/v), and extracted
with 200 ml methanol. For the MS measurements, 50 mlo ft h e
extract was diluted in 50 ml of MeOH/H2O/AcOH (49.5/49.5/
1, v/v/v). Mass spectral data were recorded by accumulation of
256 scans at 256K resolution in positive mode. The intensities of
the signals in the MS spectras were determined using the Xmass
software (Bruker, Bremen) in order to compare the concentra-
tions of dicarboxylic acid amides in the mouse urines. The
intensity of the peak corresponding to the mass of tetradecane-
dioic acid amide was used as reference for the calculation of the
concentrations of other metabolites. The intensity of the signals
corresponding to the masses of the other standard substances was
used as control for the similar behavior of dicarboxylic acid
compounds with different chain length.
Real-Time Quantitative PCR
For real-time quantitative PCR analysis of Decr and several
other genes involved in fatty acid metabolism, cDNA was
produced using a First Strand cDNA Synthesis Kit (MBI
Fermentas, Heidelberg, Germany) from total RNA isolated from
mouse liver samples with the RNeasy Mini Kit (Qiagen, Hilden,
Germany). Real-time quantitative PCR was performed with a
7500 Real Time PCR System (Applied Biosystems, Foster City,
CA, USA) using fluorogenic probe-based TaqMan chemistry with
Taqman Universal PCR Master Mix (Applied Biosystems)
according to the manufacturer’s instructions. Primers and 59
FAM-labeled probes were designed using Primer Express software
(Applied Biosystems) and the sequences available in Genbank and
were purchased from Sigma-Genosys (Sigma-Genosys, Haverhill,
UK). For relative quantification of gene expression, the results
were normalized with GAPDH as an endogenous control for each
sample and analyzed using 7500 System Software (Applied
Biosystems).
Histological Analysis
For light microscopy analysis, samples from various tissues were
fixed in 4% paraformaldehyde in potassium phosphate buffer
(100 mM, pH 7.4), embedded in paraffin, sectioned and stained
with hematoxylin and eosin. To stain the lipids, tissue samples
were embedded in O.C.T. compound (Tissue-Tek, Zoeterwoude,
Netherlands) and frozen in liquid nitrogen. Ten micrometer
cryosections were cut from frozen samples with a Reichert-Jung
2800 Frigocut cryomicrotome and stained with Oil red O and
hematoxylin using standard methods.
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Figure S1 Urine dicarboxylic acid profiles. Urine of the wild
type (dotted line) and Decr2/2 mice (solid line) was collected for
24 h (fed sample) and collection was continued for 24 h after food
removal (fasted sample). Pooled samples (5 mice/group) were
normalized to urine creatinine and analyzed with mass spectrom-
etry using tetradecanedioic acid (C14:0) as a reference. (A) Urine
dicarboxylic acid profile without fasting. (B) Urine dicarboxylic
acid profile after fasting.
Found at: doi:10.1371/journal.pgen.1000543.s001 (0.18 MB TIF)
Table S1 Amino acid analysis from sera of fasted mice. Sera of
the wild type and Decr2/2 mice were collected after 24 h fast.
Amino acids were analyzed by the clinical laboratory of the
University Hospital of Oulu, Finland. The concentrations are
expressed as means6SEM of 4 mice of each genotype per group.
Found at: doi:10.1371/journal.pgen.1000543.s002 (0.07 MB PDF)
Table S2 Urine dicarboxylic acid analysis. Urine of the wild
type and Decr2/2 mice (5 mice/group) was collected for 24 h (fed
sample) and collection was continued for 24 h after food removal
(fasted sample). Pooled samples were normalized to urine
creatinine and analyzed with mass spectrometry using tetradeca-
nedioic acid (C14:0) as a reference.
Found at: doi:10.1371/journal.pgen.1000543.s003 (0.06 MB PDF)
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